1Sesti G (2006) Pathophysiology of insulin resistance. Best Pract Res Clin Endocrinol Metab 20, 665–679.
2Ford ES, Giles WH & Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356–359.
3Ford ES, Giles WH & Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444–2449.
4Manson JE, Skerrett PJ, Greenland P & VanItallie TB (2004) The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med 164, 249–258.
5Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JP & Sjöström L (2000) Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 160, 1321–1326.
6Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F & Giugliano D (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440–1446.
7Minehira K & Tappy L (2002) Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective. Eur J Clin Nutr 56, 1264–1269.
8Ziaee V, Razaei M, Ahmadinejad Z, Shaikh H, Yousefi R, Yarmohammadi L, Bozorgi F & Behjati MJ (2006) The changes of metabolic profile and weight during Ramadan fasting. Singapore Med J 47, 409–414.
9Larijani B, Zahedi F, Sanjari M, Amini MR, Jalili RB, Adibi H & Vassigh AR (2003) The effect of Ramadan fasting on fasting serum glucose in healthy adults. Med J Malaysia 58, 678–680.
10Bouguerra R, Jabrane J, Maatki C, Ben Salem L, Hamzaoui J, El Kadhi A, Ben Rayana C & Ben Slama C (2006) Ramadan fasting in type 2 diabetes mellitus. Ann Endocrinol 67, 54–59.
11Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
13Chen H, Sullivan G & Quon MJ (2005) Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 54, 1914–1925.
14Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Okuno Y & Nishizawa Y (2003) Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 26, 2426–2432.
15Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402–2410.
16Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
17Ferrara CM & Goldberg AP (2001) Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care 24, 245–249.
18Anderson RL, Hamman RF, Savage PJ, Saad MF, Laws A, Kades WW, Sands RE & Cefalu W (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. Am J Epidemiol 142, 724–732.
19Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-D, Sands RE, Pei D, Savage PJ & Bergman RN (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43, 1114–1121.
20Yeni-Komshian H, Carantoni M, Abbasi F & Reaven GM (2000) Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23, 171–175.
21Richelsen B & Pedersen SB (1995) Associations between different anthropometric measurements of fatness and metabolic risk parameters in non-obese, healthy, middle-aged men. Int J Obes Relat Metab Disord 19, 169–174.
22Nelson W, Cadotte L & Halberg F (1973) Circadian timing of single daily meal affects survival of mice. Proc Soc Exp Biol Med 144, 766–769.
23Kassab S, Abdul-Ghaffar T, Nagalla DS, Sachdeva U & Nayar U (2004) Interactions between leptin, neuropeptide-Y and insulin with chronic diurnal fasting during Ramadan. Ann Saudi Med 24, 345–349.
24Bogdan A, Bouchareb B & Touitou Y (2001) Ramadan fasting alters endocrine and neuroendocrine circadian patterns. Meal-time as a synchronizer in humans? Life Sci 68, 1607–1615.
25Yarahmadi SH, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, Zendehdel K & Akrami SM (2003) Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Surg Pak 13, 329–332.